TEL-AVIV, Israel, Nov. 10, 2016 /PRNewswire/ -- 2breathe Technologies Ltd, a leading pioneer of digital therapeutic devices, announced that its 2breathe™ Sleep Inducer has been selected as an Innovation Award Honoree in the CES Fitness, Sports and Biotech product category. The product was showcased at CES Unveiled New York at the Metropolitan Pavilion.
CES Unveiled offers a sneak peak of year's most advanced and revolutionary technologies just before the all important holiday season and CES annual conference in January 2017. Entries are evaluated on their engineering, aesthetic and design qualities, intended use and user value, unique features present and how the innovation of the product directly compares to other products in the marketplace.
"We are excited and incredibly honored to be selected for this prestigious award," said Erez Gavish, 2breathe Technologies' co-founder and CEO, "Recognition by the Consumer Technology Association also further validates the importance of addressing sleeplessness as part the next biotech and fitness frontier."
2breathe induces sleep via guided breathing using a full-pattern Bluetooth respiration sensor and patented real-time coaching technology. Guiding tones composed from the user's breathing prolong exhalation to reduce neural sympathetic activity and induce sleep. A detailed session report shows users the number of breaths taken, how well they followed the tones and when they fell asleep.
The underlying technology for 2breathe is based on the founders' first product, RESPeRATE. Invented by Mr. Gavish and his father, scientist Dr. Benjamin Gavish, RESPeRATE is also the world's only FDA-cleared non-drug hypertension treatment device. When 90% of RESPeRATE users reported an improvement in sleep, they decided to adopt the guided-breathing technology onto a smartphone and created the 2breathe Sleep Inducer solution.
"164 million Americans struggle with sleep at least once a week," said Mr. Gavish, "While this is not terribly surprising given modern day work schedules and life stresses, it's an urgent problem given the significant toll sleeplessness has our health. Our goal at 2breathe is to help people find relief by actually inducing sleep through the ancient wisdom of guided breathing so they can get the rest they need."
According to New York-based therapist Susan Antelis, LMHC, "It's great to see an established organization like CES acknowledge 2breathe's innovative approach to a prevailing issue. Sleeplessness has 'come out of the closet.' Seeing the excellent effects of RESPeRATE to lower blood pressure with my clients, I'm delighted to see how the it has evolved to also aid sleeplessness sufferers."
2breathe was introduced to the Japanese market earlier this year by Teijin, Japan's largest sleep home care equipment provider and is now available to consumers worldwide directly at www.2breathe.com.
About 2breathe Technologies Ltd.
Tel-Aviv based 2breathe Technologies Ltd. and its founders are pioneers in the development of digital therapeutic devices, first for hypertension and now for sleeplessness. The original product, RESPeRATE® (www.resperate.com) is the world's first FDA-cleared, non-drug hypertension treatment device now used by hundreds of thousands of patients worldwide and featured in the American Heart Association statement on non-pharmacological treatments. The new product, 2breathe™, adopts RESPeRATE real-time coaching guided-breathing technology for individuals who have difficulty sleeping. For additional information, please visit www.2breathe.com.
Co-Founder & CEO
2breathe Technologies Ltd.
SOURCE 2breathe Technologies Ltd